Seikagaku Corporation (TYO:4548)

Market Cap	33.67B
Revenue (ttm)	39.37B
Net Income (ttm)	1.21B
Shares Out	54.58M
EPS (ttm)	22.25
PE Ratio	27.74
Forward PE	n/a
Dividend	30.00 (4.86%)
Ex-Dividend Date	Mar 28, 2025

Volume	228,800
Average Volume	113,710
Open	621.00
Previous Close	621.00
Day's Range	617.00 - 623.00
52-Week Range	617.00 - 914.00
Beta	0.26
RSI	26.60
Earnings Date	Aug 5, 2025

About Seikagaku

Seikagaku Corporation manufactures and sells pharmaceuticals and medical devices primarily related to glycoconjugates in Japan and internationally.The company operates in two segments, Pharmaceuticals and LAL Business. It offers pharmaceuticals and medical devices, including intra-articular injections for improving joint functions under the brands of ARTZ, ARTZ Dispo, VISCO-3, JOYCLU Gel-One, Hylink, and SUPARTZ FX; ophthalmic surgical aids under the OPEGAN and SHELLGAN brands; surgical aids for endoscopic mucosal resection under the brand name...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1947
• Employees: 1,075
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 4548

Financial Performance

In 2024, Seikagaku's revenue was 39.37 billion, an increase of 8.73% compared to the previous year's 36.21 billion. Earnings were 1.21 billion, a decrease of -44.46%.